Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 301 to 306 of 306 entries
Sorted by: Best Match Show Resources per page
LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy.

EMBO molecular medicine

Li P, Li Q, Biswas N, Xin H, Diemer T, Liu L, Perez Gutierrez L, Paternostro G, Piermarocchi C, Domanskyi S, Wang RK, Ferrara N.
PMID: 34779136
EMBO Mol Med. 2022 Jan 11;14(1):e14511. doi: 10.15252/emmm.202114511. Epub 2021 Nov 15.

In the course of our studies aiming to discover vascular bed-specific endothelial cell (EC) mitogens, we identified leukemia inhibitory factor (LIF) as a mitogen for bovine choroidal EC (BCE), although LIF has been mainly characterized as an EC growth...

Cite
Li P, Li Q, Biswas N, et al. LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy. EMBO Mol Med. 2021;14(1):e14511doi: 10.15252/emmm.202114511.
Li, P., Li, Q., Biswas, N., Xin, H., Diemer, T., Liu, L., Perez Gutierrez, L., Paternostro, G., Piermarocchi, C., Domanskyi, S., Wang, R. K., & Ferrara, N. (2022). LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy. EMBO molecular medicine, 14(1), e14511. https://doi.org/10.15252/emmm.202114511
Li, Pin, et al. "LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy." EMBO molecular medicine vol. 14,1 (2022): e14511. doi: https://doi.org/10.15252/emmm.202114511
Li P, Li Q, Biswas N, Xin H, Diemer T, Liu L, Perez Gutierrez L, Paternostro G, Piermarocchi C, Domanskyi S, Wang RK, Ferrara N. LIF, a mitogen for choroidal endothelial cells, protects the choriocapillaris: implications for prevention of geographic atrophy. EMBO Mol Med. 2022 Jan 11;14(1):e14511. doi: 10.15252/emmm.202114511. Epub 2021 Nov 15. PMID: 34779136; PMCID: PMC8749470.
Copy Download .nbib Format: NLM
Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis.

Pharmaceutics

Soond SM, Savvateeva LV, Makarov VA, Gorokhovets NV, Townsend PA, Zamyatnin AA.
PMID: 33807987
Pharmaceutics. 2021 Mar 05;13(3). doi: 10.3390/pharmaceutics13030339.

Certain lysosomal cathepsin proteins have come into focus as being good candidates for therapeutic targeting, based on them being over-expressed in a variety of cancers and based on their regulation of the apoptotic pathway. Here, we report novel findings...

Cite
Soond SM, Savvateeva LV, Makarov VA, et al. Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis. Pharmaceutics. 2021;13(3)doi: 10.3390/pharmaceutics13030339.
Soond, S. M., Savvateeva, L. V., Makarov, V. A., Gorokhovets, N. V., Townsend, P. A., & Zamyatnin, A. A. (2021). Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis. Pharmaceutics, 13(3), . https://doi.org/10.3390/pharmaceutics13030339
Soond, Surinder M, et al. "Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis." Pharmaceutics vol. 13,3 (2021). doi: https://doi.org/10.3390/pharmaceutics13030339
Soond SM, Savvateeva LV, Makarov VA, Gorokhovets NV, Townsend PA, Zamyatnin AA. Cathepsin S Cleaves BAX as a Novel and Therapeutically Important Regulatory Mechanism for Apoptosis. Pharmaceutics. 2021 Mar 05;13(3). doi: 10.3390/pharmaceutics13030339. PMID: 33807987; PMCID: PMC8035670.
Copy Download .nbib Format: NLM
Cysteine cathepsins are altered by flow within an engineered .

APL bioengineering

Douglas SA, Haase K, Kamm RD, Platt MO.
PMID: 33195960
APL Bioeng. 2020 Nov 04;4(4):046102. doi: 10.1063/5.0023342. eCollection 2020 Dec.

Throughout the process of vascular growth and remodeling, the extracellular matrix (ECM) concurrently undergoes significant changes due to proteolytic activity-regulated by both endothelial and surrounding stromal cells. The role of matrix metalloproteinases has been well-studied in the context of...

Cite
Douglas SA, Haase K, Kamm RD, et al. Cysteine cathepsins are altered by flow within an engineered . APL Bioeng. 2020;4(4):046102doi: 10.1063/5.0023342.
Douglas, S. A., Haase, K., Kamm, R. D., & Platt, M. O. (2020). Cysteine cathepsins are altered by flow within an engineered . APL bioengineering, 4(4), 046102. https://doi.org/10.1063/5.0023342
Douglas, Simone A, et al. "Cysteine cathepsins are altered by flow within an engineered ." APL bioengineering vol. 4,4 (2020): 046102. doi: https://doi.org/10.1063/5.0023342
Douglas SA, Haase K, Kamm RD, Platt MO. Cysteine cathepsins are altered by flow within an engineered . APL Bioeng. 2020 Nov 04;4(4):046102. doi: 10.1063/5.0023342. eCollection 2020 Dec. PMID: 33195960; PMCID: PMC7644274.
Copy Download .nbib Format: NLM
Understanding the cross-talk between mediators of infertility and COVID-19.

Reproductive biology

Rajak P, Roy S, Dutta M, Podder S, Sarkar S, Ganguly A, Mandi M, Khatun S.
PMID: 34547545
Reprod Biol. 2021 Dec;21(4):100559. doi: 10.1016/j.repbio.2021.100559. Epub 2021 Sep 01.

COVID-19 is the ongoing health emergency affecting individuals of all ages around the globe. Initially, the infection was reported to affect pulmonary structures. However, recent studies have delineated the impacts of COVID-19 on the reproductive system of both men...

Cite
Rajak P, Roy S, Dutta M, et al. Understanding the cross-talk between mediators of infertility and COVID-19. Reprod Biol. 2021;21(4):100559doi: 10.1016/j.repbio.2021.100559.
Rajak, P., Roy, S., Dutta, M., Podder, S., Sarkar, S., Ganguly, A., Mandi, M., & Khatun, S. (2021). Understanding the cross-talk between mediators of infertility and COVID-19. Reproductive biology, 21(4), 100559. https://doi.org/10.1016/j.repbio.2021.100559
Rajak, Prem, et al. "Understanding the cross-talk between mediators of infertility and COVID-19." Reproductive biology vol. 21,4 (2021): 100559. doi: https://doi.org/10.1016/j.repbio.2021.100559
Rajak P, Roy S, Dutta M, Podder S, Sarkar S, Ganguly A, Mandi M, Khatun S. Understanding the cross-talk between mediators of infertility and COVID-19. Reprod Biol. 2021 Dec;21(4):100559. doi: 10.1016/j.repbio.2021.100559. Epub 2021 Sep 01. PMID: 34547545; PMCID: PMC8407955.
Copy Download .nbib Format: NLM
Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V.

Frontiers in genetics

Eckl KM, Gruber R, Brennan L, Marriott A, Plank R, Moosbrugger-Martinz V, Blunder S, Schossig A, Altmüller J, Thiele H, Nürnberg P, Zschocke J, Hennies HC, Schmuth M.
PMID: 34322157
Front Genet. 2021 Jul 12;12:689940. doi: 10.3389/fgene.2021.689940. eCollection 2021.

Keratosis follicularis spinulosa decalvans (KFSD) is a rare cornification disorder with an X-linked recessive inheritance in most cases. Pathogenic variants causing X-linked KFSD have been described in

Cite
Eckl KM, Gruber R, Brennan L, et al. Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V. Front Genet. 2021;12:689940doi: 10.3389/fgene.2021.689940.
Eckl, K. M., Gruber, R., Brennan, L., Marriott, A., Plank, R., Moosbrugger-Martinz, V., Blunder, S., Schossig, A., Altmüller, J., Thiele, H., Nürnberg, P., Zschocke, J., Hennies, H. C., & Schmuth, M. (2021). Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V. Frontiers in genetics, 12689940. https://doi.org/10.3389/fgene.2021.689940
Eckl, Katja M, et al. "Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V." Frontiers in genetics vol. 12 (2021): 689940. doi: https://doi.org/10.3389/fgene.2021.689940
Eckl KM, Gruber R, Brennan L, Marriott A, Plank R, Moosbrugger-Martinz V, Blunder S, Schossig A, Altmüller J, Thiele H, Nürnberg P, Zschocke J, Hennies HC, Schmuth M. Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V. Front Genet. 2021 Jul 12;12:689940. doi: 10.3389/fgene.2021.689940. eCollection 2021. PMID: 34322157; PMCID: PMC8312243.
Copy Download .nbib Format: NLM
17β-Estradiol and cathepsins control primordial follicle growth in mouse ovaries.

Reproduction (Cambridge, England)

Komatsu K, Wei W, Murase T, Masubuchi S.
PMID: 34324431
Reproduction. 2021 Sep 06;162(4):277-287. doi: 10.1530/REP-20-0599.

This study aimed to clarify the physiological mechanism regulating the growth of primordial follicles in mouse ovaries. In a previous study, we found that increasing the fetal bovine serum concentration in the culture medium promoted the growth of primordial...

Cite
Komatsu K, Wei W, Murase T, et al. 17β-Estradiol and cathepsins control primordial follicle growth in mouse ovaries. Reproduction. 2021;162(4):277-287doi: 10.1530/REP-20-0599.
Komatsu, K., Wei, W., Murase, T., & Masubuchi, S. (2021). 17β-Estradiol and cathepsins control primordial follicle growth in mouse ovaries. Reproduction (Cambridge, England), 162(4), 277-287. https://doi.org/10.1530/REP-20-0599
Komatsu, Kouji, et al. "17β-Estradiol and cathepsins control primordial follicle growth in mouse ovaries." Reproduction (Cambridge, England) vol. 162,4 (2021): 277-287. doi: https://doi.org/10.1530/REP-20-0599
Komatsu K, Wei W, Murase T, Masubuchi S. 17β-Estradiol and cathepsins control primordial follicle growth in mouse ovaries. Reproduction. 2021 Sep 06;162(4):277-287. doi: 10.1530/REP-20-0599. PMID: 34324431.
Copy Download .nbib Format: NLM
Showing 301 to 306 of 306 entries